𝔖 Bobbio Scriptorium
✦   LIBER   ✦

P2.103 Antidyskinetic effects of levetiracetam on levodopa-induced dyskinesias in Parkinson's disease: a randomised, double-blind, placebo-controlled trial

✍ Scribed by M. Löhle; M. Wolz; K. Strecker; C. Schneider; U. Schwanebeck; H. Reichmann; X. Grählert; J. Schwarz; A. Storch


Book ID
117753657
Publisher
Elsevier Science
Year
2009
Tongue
English
Weight
82 KB
Volume
15
Category
Article
ISSN
1353-8020

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


A randomized, double-blind, placebo-cont
✍ Kitty K. Wong; Jane E. Alty; Amanda G. Goy; Sanjay Raghav; David C. Reutens; Pet 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 565 KB

## Abstract ## Background: This randomized double blind, placebo‐controlled crossover study investigated the antidyskinetic effects of levetiracetam in Parkinson's disease. ## Methods: Sixteen participants with levodopa‐induced dyskinesia were enrolled. Hourly videotaped dyskinesia assessments s

Acute effects of immediate and controlle
✍ Jaime Kulisevsky; Berta Pascual-Sedano; Manel Barbanoj; Alexandre Gironell; Javi 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB 👁 1 views

Mood fluctuations related to levodopa (LD) dosing are well-known psychiatric complications of Parkinson's disease (PD). No formal studies explored how affective response to LD relates to the type of motor response to oral LD (stable or wearing-off) and to different pharmacokinetic profiles of oral L